Publicacións en colaboración con investigadores/as de Universidad de Alcalá (22)

2024

  1. Characterization of the plasma proteomic profile of Fabry disease: Potential sex- and clinical phenotype-specific biomarkers

    Translational Research, Vol. 269, pp. 47-63

  2. Should we measure quality of life among people with HIV? A multicentre survey of physicians' opinions in Spain

    HIV Medicine

2023

  1. Incidence of Anal Cancer and Related Risk Factors in HIV-Infected Patients Enrolled in the National Prospective Spanish Cohort CoRIS

    Diseases of the Colon and Rectum, Vol. 66, Núm. 12, pp. E1186-E1194

  2. Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1

    Journal of Infectious Diseases

  3. Metabolic-Related Outcomes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Adults With Human Immunodeficiency Virus (HIV): A Multicenter Prospective Cohort Study

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 76, Núm. 3, pp. e652-e660

2022

  1. Left ventricular diastolic dysfunction in systemic sclerosis: Clinical, immunological and survival differences in the Spanish RESCLE registry

    Seminars in Arthritis and Rheumatism, Vol. 55

  2. Similar CD4/CD8 Ratio Recovery After Initiation of Dolutegravir Plus Lamivudine Versus Dolutegravir or Bictegravir-Based Three-Drug Regimens in Naive Adults With HIV

    Frontiers in immunology, Vol. 13, pp. 873408

2021

  1. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  2. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  3. Predicting critical illness on initial diagnosis of COVID-19 based on easily obtained clinical variables: development and validation of the PRIORITY model

    Clinical Microbiology and Infection, Vol. 27, Núm. 12, pp. 1838-1844

2020

  1. Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: The BACS score

    European Respiratory Journal, Vol. 56, Núm. 6

2018

  1. Awareness, knowledge, use, willingness to use and need of Pre-Exposure Prophylaxis (PrEP) during World Gay Pride 2017

    PLoS ONE, Vol. 13, Núm. 10

2017

  1. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

    American Journal of Medicine, Vol. 130, Núm. 5, pp. 588-595

2014

  1. Desarrollo de guías de práctica clínica en pacientes con comorbilidad y pluripatología

    Atencion Primaria, Vol. 46, Núm. 7, pp. 385-392

  2. Desarrollo de guías de práctica clínica en pacientes con comorbilidad y pluripatología

    Revista Clinica Espanola, Vol. 214, Núm. 6, pp. 328-335

  3. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2009

  1. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection

    Journal of Viral Hepatitis, Vol. 16, Núm. 4, pp. 249-258

2008

  1. Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status

    International Journal of Tuberculosis and Lung Disease, Vol. 12, Núm. 12, pp. 1393-1400

2006

  1. Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature

    Human Pathology, Vol. 37, Núm. 10, pp. 1344-1349

  2. Viral kinetics and early prediction of nonresponse to peg-IFN-α-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus

    Journal of Viral Hepatitis, Vol. 13, Núm. 7, pp. 466-473